Complexity and heterogeneity are frequently present during the development and progression of carcinogenesis and, in the last 15 years, significant progress made in clinical research underlines the role of
some epigenetic mechanisms. The most important characteristics of the epigenetic concept are that these
events are reversible, not related to modifications in the structure of DNA and may drive fundamental cell
signaling alterations1. Among these systems of communication in normal and pathological conditions,
also microbiome and staminal cells2 seem to be important. These new profiles of pathological communication develop novel diagnostic, prognostic and therapeutic tool